2012; 366:2455 –65. PF-06936308 C3621001 Final Protocol Amendment 2, 22 Dec 2020 PFIZER CONFIDENTIAL Page 13675. Topalian SL , Sznol M, McDermott DF, et al. Survival, durable tumor remission, and long-term safet y in patients with advanced melanomarecei ving nivolumab. J Clin Oncol. 2014; 32:1020–30. 76. Lipson EJ, Vicent JG, L oyo M, et al. PD -L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell poly omavirus and overall survival. Cancer Immunol Re.